Brian Burkavage's most recent trade in IO Biotech Inc was a trade of 65,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 2, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
IO Biotech Inc | Brian Burkavage | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2025 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
IO Biotech Inc | Brian Burkavage | Chief Accounting Officer | 15 Mar 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | ||
IO Biotech Inc | Brian Burkavage | Chief Accounting Officer | 20 Mar 2023 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | ||
IO Biotech Inc | Brian Burkavage | Chief Accounting Officer | 31 May 2022 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) |